Association of Daytime Sleepiness with COMT Polymorphism in Patients with Parkinson Disease: a Pilot Study
Open Access
- 1 June 2004
- journal article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 27 (4) , 733-736
Abstract
To evaluate an association between catechol-O-methyltransferase (COMT) genotype and subjective daytime sleepiness in patients with Parkinson disease. Structured questionnaire study. Tertiary Parkinson disease care center and sleep outpatients’ department at the university hospital neurology department. All nondemented patients with idiopathic Parkinson disease who had been part of a previous study of D4-receptor polymorphisms in 1997 were eligible to participate. From the original sample of 113 patients, 46 participated in the study, 22 met exclusion criteria, and 43 were not available. Not applicable. In this study, 46 patients were included (27 men, 19 women; 68.4 ± 9.9 years of age; symptomatic disease duration, 12.2 ± 5.2 years; Hoehn and Yahr stage in “on” of 2.6 ± 0.8). Out of the 46 patients, 13 had LL genotype, 22 HL, and 11 HH. The Epworth Sleepiness Scale scores were 9.5 ± 4.8 in LL, 8.5 ± 4.7 in HL, and 6.8 ± 3.1 in HH (mean ± SD) (NS). LL and LH were grouped together. The Epworth Sleepiness Scale score was 11 or more in 40% of the LL+LH group, compared to 9.1% of the HH group (P = .039). The levodopa or dopamine-agonist doses and types did not differ between the LL+LH group versus the HH group. These preliminary data suggest an association of the L-allele and daytime sleepiness in patients with Parkinson disease.Keywords
This publication has 15 references indexed in Scilit:
- Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's diseaseMovement Disorders, 2003
- Increased daytime sleepiness in Parkinson's disease: A questionnaire surveyMovement Disorders, 2002
- Modafinil for the Treatment of Daytime Sleepiness in Parkinson´s Disease: A Double-blind, Randomized, Crossover, Placebo-controlled Polygraphic TrialSLEEP, 2002
- Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinilThe Pharmacogenomics Journal, 2002
- Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): Placebo‐controlled, polysomnographic case reportMovement Disorders, 2001
- MAO-A and COMT polymorphisms and gene effects in narcolepsyMolecular Psychiatry, 2001
- The multiple sleep latency test and Epworth sleepiness scale in the assessment of daytime sleepinessJournal of Sleep Research, 2000
- Dopamine D4 receptor polymorphism and idiopathic Parkinson's diseaseEuropean Journal of Human Genetics, 1999
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleSLEEP, 1991